Risedronate therapy for prevention of hip fracture after stroke in elderly women

Neurology

Volumn 64, Issue 5, 2005, Pages 811-816

  Sato, Yoshihiro ^a   Iwamoto, Jun ^b   Kanoko, Tomohiro ^c   Satoh, Kei ^c  

^a Mitate Hospital   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; MARKER; PARATHYROID HORMONE; RISEDRONIC ACID;

AGED; ARTICLE; BARTHEL INDEX; BONE DENSITY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEMIPLEGIA; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPOROSIS; PARALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STROKE; VITAMIN D DEFICIENCY;

EID: 14644438517     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000152871.65027.76     Document Type: Article

References (31)

1. Shahar E, McGovern PG, Sprafka JM, et al. Improved survival of stroke patients during the 1980s. The Minnesota stroke survey. Stroke 1995;21:1-6.
2. Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures. BMJ 1994;307:1248-1250.
3. Ramnemark A, Nyberg L, Borssén B, Olsson T, Gustafson Y. Fractures after stroke. Osteoporos Int 1998;8:92-95.
4. Chiu KY, Pun WK, Luk KDK, Chow SP. A prospective study on hip fractures in patients with previous cerebrovascular accidents. Injury 1992;23:297-299.
5. Hooper G. Internal fixation of fractures of the neck of the femur in hemiplegic patients. Injury 1979;10:281-284.
6. Poplingher AR, Pillar T. Hip fracture in stroke patients. Acta Orthop Scand 1985;56:226-227.
7. Sato Y, Maruoka H, Honda Y, Asoh T, Fujimatsu Y, Oizumi K. Development osteopenia in the hemiplegic finger in patients with stroke. Eur Neurol 1996;36:278-283.
8. Sato Y, Kuno H, Kaji M, Ohshima Y, Asoh T, Oizumi K. Increased bone resorption during the first year following a stroke. Stroke 1998;29:1373-1377.
9. Sato Y, Maruoka H, Oizumi K, Kikuyama M. Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. Stroke 1996;27:2183-2187.
10. Sato Y, Kuno H, Kaji M, Etoh K, Oizumi K. Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke. J Neurol Sci 2000;175:135-139.
11. Sato Y, Maruoka H, Oizumi K. Amelioration of hemiplegia-associated osteopenia over 4 years following stroke by 1 α-hydroxyvitamin D3 and calcium supplementation. Stroke 1997;28:736-739.
12. Sato Y, Honda Y, Kuno H, Oizumi K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K- deficient stroke patients. Bone 1998;23:291-296.
13. Sato Y, Kuno H, Kaji M, Saruwatari N, Oizumi K. Effect of ipriflavone on bone in elderly hemiplegic stroke patients with hypovitaminosis D. Am J Phys Med Rehabil 1999;78:457-463.
14. Sato Y, Asoh T, Kaji M, Oizumi K. Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke. J Bone Mineral Res 2000;15:2487-2494.
15. van Beek ER, Cohen LH, Leroy IM, Ebetino FH, Lowik CW, Papapoulos SE. Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates. Bone 2003;33:805-811.
16. Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83-91.
17. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-340.
18. Fukunaga M, Kushida K, Kishimoto H, et al. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial. Osteoporos Int 2002;13:971-979.
19. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Md St Med J 1965;14:61-65.
20. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke - Background and study protocol. Stroke 1985;16:885-890.
21. Matsumoto C, Kushida K, Yamazaki K, Imose K, Inoue T. Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry. Calcif Tissue Int 1994;55:324-329.
22. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest 1991;21:310-315.
23. Komar L, Nieves J, Cosman F, Rubin A, Shen V, Lindsay R. Calcium homeostasis of an elderly population upon admission to a nursing home. J Am Geriatr Soc 1993;41:1057-1064.
24. Sato Y, Honda Y, Kaji M, Asoh T, Hosokawa K, Kondo I. Amelioration of osteopenia by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 2002;31:114-118.
25. Sato Y, Manabe S, Kuno H, Oizumi K. Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;66:64-68.
26. Derisquebourg T, Dubois P, Devogelaer JP, et al. Automated computerized radiogrammetry of the second metacarpal and its correlation with absorptiometry of the forearm and spine. Calcif Tissue Int 1994;54:461-465.
27. Thomas MK, Lloyd-Jones DM, Thandhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777-783.
28. Holick MF. The use and interpretation of assays for vitamin D and its metabolites. J Nutr 1990;120:S1464-S1469.
29. Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 1982;306:1136-1140.
30. Sato Y, Fujimatsu Y, Kikuyama M, Kaji M, Oizumi K. Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke. J Neurol Sci 1998;156:205-210.
31. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-1642.